Obesity Drug's Mid-Stage Win; Endocrine Disease Disparities; Chewing Away Diabetes?
(MedPage Today) -- An investigational dual glucagon/GLP-1 receptor agonist helped people with obesity or overweight, but without diabetes, shed about 15% of their body weight by 46 weeks in a phase II trial, Boehringer Ingelheim and Zealand Pharma... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 17, 2023 Category: Endocrinology Source Type: news
Doctors 'Depart' Texas Clinic Amid Transgender Care Probe
(MedPage Today) -- The physicians who staffed Dell Children's Medical Center's adolescent medicine clinic in Austin, Texas are departing amid an investigation by the state's attorney general, according to clinic officials.
Tweets and TikToks claimed... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 16, 2023 Category: Endocrinology Source Type: news
Weighing the Consequences of Weight-Loss Drugs
(MedPage Today) -- Tirzepatide (Mounjaro), perhaps with a new brand name, will likely join semaglutide (Wegovy) by year's end as an approved weight-loss treatment for people with obesity or overweight and at least one weight-related medical problem... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 12, 2023 Category: Endocrinology Source Type: news
Once-Weekly Insulin Icodec Wins; Wegovy Heart Data Soon; AACE's T2D Algorithm Update
(MedPage Today) -- Compared with once-daily insulin glargine U100, once-weekly icodec performed similarly for glycemic control, but needed fewer basal insulin injections and a lower bolus insulin dose, and had no increase in hypoglycemic rates... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 9, 2023 Category: Endocrinology Source Type: news
Novel Drug Fails to Improve Diabetic Retinopathy, but Slows Progression
(MedPage Today) -- SAN DIEGO -- A novel oral angiogenesis inhibitor failed to improve diabetic retinopathy but significantly slowed the rate of progression in a randomized placebo-controlled trial.
Numerically, more study eyes treated with the... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 9, 2023 Category: Endocrinology Source Type: news
Novel Hormone Replacer Holds Up Long-Term for Hypoparathyroidism
(MedPage Today) -- SEATTLE -- Nearly all patients with chronic hypoparathyroidism were able to remain off conventional therapy with active vitamin D and calcium long-term after treatment with an investigational prodrug, according to the phase... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 8, 2023 Category: Endocrinology Source Type: news
Higher BMI Tied to Other Severe Respiratory Infections Too
(MedPage Today) -- A higher body mass index (BMI) was associated with increased risks for hospitalization and death due to COVID-19 and other respiratory infections as well, according to a study using data from the U.K. Biobank.
After a mean follow... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 3, 2023 Category: Endocrinology Source Type: news
Prednisone Did Not Improve Live Birth Rates for Women With Recurrent IVF Failure
(MedPage Today) -- Treatment with prednisone did not improve live birth rates among women with recurrent implantation failure compared with placebo, a randomized trial from China showed.
Of over 700 women included in the intention-to-treat analysis... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 2, 2023 Category: Endocrinology Source Type: news
FDA Turns Down TransCon PTH; Black Market Hormones; Pandemic Thyroid Tumors
(MedPage Today) -- Denmark's Ascendis Pharma announced that the FDA declined to approve the company's new drug application for the hypoparathyroidism drug palopegteriparatide (TransCon PTH) due to manufacturing concerns.
Workdays missed because... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 2, 2023 Category: Endocrinology Source Type: news
Bariatric-Metabolic Surgery More Effective Than Lifestyle Change for NASH
(MedPage Today) -- Two types of bariatric-metabolic surgery were more effective than lifestyle modification plus best medical care in the treatment of non-alcoholic steatohepatitis (NASH), a randomized trial from Italy showed.
In over 200 patients... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - April 26, 2023 Category: Endocrinology Source Type: news
Weight Loss Giants Going Head-to-Head; FDA OKs Omnipod GO; GLP-1 Drugs for Wolfram?
(MedPage Today) -- Eli Lilly plans to test its diabetes drug and weight loss treatment candidate tirzepatide (Mounjaro) in a head-to-head trial against Novo Nordisk's semaglutide (Wegovy). (Endpoints News)
One extreme risk of semaglutide for weight... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - April 25, 2023 Category: Endocrinology Source Type: news
FDA Finally OKs Latest MiniMed System for Type 1 Diabetes
(MedPage Today) -- The FDA approved Medtronic's latest MiniMed insulin pump system, the company announced late last week.
Indicated for individuals with type 1 diabetes ages 7 and older, the MiniMed 780G system pairs the fingerstick-free Guardian... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - April 24, 2023 Category: Endocrinology Source Type: news
Bone Density Loss Seen After Bariatric Surgery in Teens
(MedPage Today) -- Although bariatric surgery is quite effective for weight loss in teens with obesity, it also may weaken the bones, according to a prospective longitudinal study.
Over the course of 1 year after undergoing sleeve gastrectomy... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - April 20, 2023 Category: Endocrinology Source Type: news
New Reader for FreeStyle Libre 3; COVID Bumps Diabetes Risk; Tepezza Label Expanded
(MedPage Today) -- The FDA cleared a new standalone reader for the FreeStyle Libre 3 continuous glucose monitor that will help in getting the system closer to being covered by Medicare, said maker Abbott.
In a study looking at the diets of people... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - April 18, 2023 Category: Endocrinology Source Type: news
Pioneering Lung Transplant; Regulators and Weight-Loss Drugs; Psychedelic Long COVID
(MedPage Today) -- Note that some links may require subscriptions.
A hospital in Barcelona, Spain, has reportedly performed a lung transplant using a pioneering technique via robot that avoids cutting through bone. (Reuters)
Stateside, federal... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - April 18, 2023 Category: Endocrinology Source Type: news
